The Roskamp Institute is a biotechnology startup based in Sarasota, Florida, founded in 2003. The institute is focused on understanding the causes of neuropsychiatric and neurodegenerative disorders and addictions, with a particular emphasis on Alzheimer's disease.
Headed by Dr. Michael Mullan and Dr. Fiona Crawford, the institute is renowned for its devotion to conducting high-quality research. The team consists of experienced and interdisciplinary scientists and technicians who utilize state-of-the-art research labs and equipment to advance their work. Their slogan, "Better Science. Real Discovery.", reflects the commitment to producing impactful outcomes.
Although specific investment details are not available, The Roskamp Institute presents an intriguing opportunity for potential venture capital investors due to its focused approach, experienced leadership, and the critical importance of their research in the field of neurodegenerative disorders. With its dedication to better science and real discovery, the institute is positioned to make significant contributions to the biotechnology industry and the understanding and treatment of neuropsychiatric and neurodegenerative disorders.
There is no investment information
No recent news or press coverage available for The Roskamp Institute.